{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:40:40Z","timestamp":1792518040582,"version":"4.5.0"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T00:00:00Z","timestamp":1671408000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017054","name":"National Natural Science Foundation of China Zhejiang Joint Fund for the Integration of Industrialization and Informatization","doi-asserted-by":"publisher","award":["81790631"],"award-info":[{"award-number":["81790631"]}],"id":[{"id":"10.13039\/100017054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003345","name":"Chinese Academy of Meteorological Sciences","doi-asserted-by":"publisher","award":["2019-I2M-5\u2013045"],"award-info":[{"award-number":["2019-I2M-5\u2013045"]}],"id":[{"id":"10.13039\/501100003345","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2018YFC2000500"],"award-info":[{"award-number":["2018YFC2000500"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFA1301104"],"award-info":[{"award-number":["2021YFA1301104"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFC2301804"],"award-info":[{"award-number":["2021YFC2301804"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.redox.2022.102582","type":"journal-article","created":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T12:27:26Z","timestamp":1671712046000},"page":"102582","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["Microbiota-induced lipid peroxidation impairs obeticholic acid-mediated antifibrotic effect towards nonalcoholic steatohepatitis in mice"],"prefix":"10.1016","volume":"59","author":[{"given":"Aoxiang","family":"Zhuge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengyi","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiafeng","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiangqiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengcheng","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanjuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.redox.2022.102582_bib1","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0092-8674(00)00062-3","article-title":"Targeted disruption of the nuclear receptor FXR\/BAR impairs bile acid and lipid homeostasis","volume":"102","author":"Sinal","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.redox.2022.102582_bib2","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1126\/science.1121435","article-title":"Nuclear receptor-dependent bile acid signaling is required for normal liver regeneration","volume":"312","author":"Huang","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.redox.2022.102582_bib3","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1172\/JCI25604","article-title":"Farnesoid X receptor is essential for normal glucose homeostasis","volume":"116","author":"Ma","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.redox.2022.102582_bib4","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1101\/gad.1138104","article-title":"Peroxisome proliferator-activated receptor-gamma coactivator 1alpha (PGC-1alpha) regulates triglyceride metabolism by activation of the nuclear receptor FXR","volume":"18","author":"Zhang","year":"2004","journal-title":"Genes Dev."},{"key":"10.1016\/j.redox.2022.102582_bib5","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41575-020-00404-2","article-title":"The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer","volume":"18","author":"Sun","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.redox.2022.102582_bib6","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0140-6736(20)31607-X","article-title":"Primary biliary cholangitis","volume":"396","author":"Lleo","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.redox.2022.102582_bib7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41575-020-00406-0","article-title":"Nonalcoholic fatty liver disease: another leap forward","volume":"18","author":"Abdelmalek","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.redox.2022.102582_bib8","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jhep.2020.02.033","article-title":"A randomized, placebo-controlled, phase II study of obeticholic acid for primary sclerosing cholangitis","volume":"73","author":"Kowdley","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.redox.2022.102582_bib9","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1016\/S0140-6736(19)33041-7","article-title":"Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial","volume":"394","author":"Younossi","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.redox.2022.102582_bib10","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1016\/S0140-6736(19)32963-0","article-title":"Obeticholic acid: towards first approval for NASH","volume":"394","author":"Eslam","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.redox.2022.102582_bib11","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMoa1509840","article-title":"A placebo-controlled trial of obeticholic acid in primary biliary cholangitis","volume":"375","author":"Nevens","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.redox.2022.102582_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-33070-1","article-title":"FXR agonist obeticholic acid induces liver growth but exacerbates biliary injury in rats with obstructive cholestasis","volume":"8","author":"van Golen","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.redox.2022.102582_bib13","doi-asserted-by":"crossref","DOI":"10.1007\/s00204-022-03266-6","article-title":"Farnesoid X receptor (FXR) agonists induce hepatocellular apoptosis and impair hepatic functions via FXR\/SHP pathway","author":"Zhang","year":"2022","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.redox.2022.102582_bib14","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.apsb.2018.11.004","article-title":"Combined obeticholic acid and apoptosis inhibitor treatment alleviates liver fibrosis","volume":"9","author":"Zhou","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.redox.2022.102582_bib15","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1053\/j.gastro.2014.12.005","article-title":"Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid","volume":"148","author":"Hirschfield","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.redox.2022.102582_bib16","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.jhep.2019.06.011","article-title":"Obeticholic acid may increase the risk of gallstone formation in susceptible patients","volume":"71","author":"Al-Dury","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.redox.2022.102582_bib17","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.redox.2022.102582_bib18","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.redox.2022.102582_bib19","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.hbpd.2021.04.007","article-title":"Cross-talk between hepatic stellate cells and T lymphocytes in liver fibrosis","volume":"20","author":"Li","year":"2021","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"10.1016\/j.redox.2022.102582_bib20","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jhep.2020.04.001","article-title":"Lytic cell death in metabolic liver disease","volume":"73","author":"Gautheron","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.redox.2022.102582_bib21","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s41419-022-04708-w","article-title":"Mesenchymal stem cells protect against ferroptosis via exosome-mediated stabilization of SLC7A11 in acute liver injury","volume":"13","author":"Lin","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.redox.2022.102582_bib22","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/s41419-019-1678-y","article-title":"Hepatic ferroptosis plays an important role as the trigger for initiating inflammation in nonalcoholic steatohepatitis","volume":"10","author":"Tsurusaki","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.redox.2022.102582_bib23","doi-asserted-by":"crossref","first-page":"54677","DOI":"10.1021\/acsami.1c14674","article-title":"Fluorescent egg white-based carbon dots as a high-sensitivity iron chelator for the therapy of nonalcoholic fatty liver disease by iron overload in zebrafish","volume":"13","author":"Yu","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.redox.2022.102582_bib24","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/hep.24038","article-title":"Relationship between the pattern of hepatic iron deposition and histological severity in nonalcoholic fatty liver disease","volume":"53","author":"Nelson","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.redox.2022.102582_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154797","article-title":"A new mechanism of obeticholic acid on NASH treatment by inhibiting NLRP3 inflammasome activation in macrophage","volume":"120","author":"Huang","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.redox.2022.102582_bib26","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2013.05.042","article-title":"Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease","volume":"145","author":"Mudaliar","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.redox.2022.102582_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/s41401-021-00849-4","article-title":"FXR: structures, biology, and drug development for NASH and fibrosis diseases","author":"Tian","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.redox.2022.102582_bib28","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S2213-8587(18)30154-2","article-title":"Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies","volume":"7","author":"Stefan","year":"2019","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.redox.2022.102582_bib29","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/dom.12681","article-title":"Effects of obeticholic acid on lipoprotein metabolism in healthy volunteers","volume":"18","author":"Pencek","year":"2016","journal-title":"Diabetes Obes. Metabol."},{"key":"10.1016\/j.redox.2022.102582_bib30","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0140-6736(14)61933-4","article-title":"Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial","volume":"385","author":"Neuschwander-Tetri","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.redox.2022.102582_bib31","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nrd.2015.3","article-title":"Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies","volume":"15","author":"Musso","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.redox.2022.102582_bib32","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.cell.2018.09.053","article-title":"Obesity drives STAT-1-dependent NASH and STAT-3-dependent HCC","volume":"175","author":"Grohmann","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.redox.2022.102582_bib33","doi-asserted-by":"crossref","first-page":"830","DOI":"10.3892\/etm.2021.10262","article-title":"Co-administration of obeticholic acid and simvastatin protects against high-fat diet-induced non-alcoholic steatohepatitis in mice","volume":"22","author":"Li","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.redox.2022.102582_bib34","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.molmet.2017.09.001","article-title":"Superior reductions in hepatic steatosis and fibrosis with co-administration of a glucagon-like peptide-1 receptor agonist and obeticholic acid in mice","volume":"6","author":"Jouihan","year":"2017","journal-title":"Mol. Metabol."},{"key":"10.1016\/j.redox.2022.102582_bib35","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ejphar.2017.11.021","article-title":"Obeticholic acid raises LDL-cholesterol and reduces HDL-cholesterol in the Diet-Induced NASH (DIN) hamster model","volume":"818","author":"Briand","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.redox.2022.102582_bib36","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/s41467-019-14138-6","article-title":"SUMOylation inhibitors synergize with FXR agonists in combating liver fibrosis","volume":"11","author":"Zhou","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.redox.2022.102582_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2022.01.020","article-title":"Interruption of bile acid uptake by hepatocytes after acetaminophen overdose ameliorates hepatotoxicity","author":"Ghallab","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.redox.2022.102582_bib38","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1053\/j.gastro.2011.02.054","article-title":"Reactive oxygen species induced by bile acid induce apoptosis and protect against necrosis in pancreatic acinar cells","volume":"140","author":"Booth","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.redox.2022.102582_bib39","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/nrgastro.2010.172","article-title":"The role of the gut microbiota in nonalcoholic fatty liver disease","volume":"7","author":"Abu-Shanab","year":"2010","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.redox.2022.102582_bib40","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.freeradbiomed.2016.10.495","article-title":"Redox signaling mediated by the gut microbiota","volume":"105","author":"Jones","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2022.102582_bib41","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.redox.2018.01.009","article-title":"Role of gut microbiota and oxidative stress in the progression of non-alcoholic fatty liver disease to hepatocarcinoma: current and innovative therapeutic approaches","volume":"15","author":"Borrelli","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2022.102582_bib42","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.cmet.2021.06.012","article-title":"FXR activation protects against NAFLD via bile-acid-dependent reductions in lipid absorption","volume":"33","author":"Clifford","year":"2021","journal-title":"Cell Metabol."},{"key":"10.1016\/j.redox.2022.102582_bib43","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1053\/j.gastro.2018.06.031","article-title":"Bioactive lipid species and metabolic pathways in progression and resolution of nonalcoholic steatohepatitis","volume":"155","author":"Musso","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.redox.2022.102582_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2021.101144","article-title":"Dietary lipids from body to brain","volume":"85","author":"Custers","year":"2022","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.redox.2022.102582_bib45","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.cmet.2021.05.016","article-title":"Peroxidation of n-3 and n-6 polyunsaturated fatty acids in the acidic tumor environment leads to ferroptosis-mediated anticancer effects","volume":"33","author":"Dierge","year":"2021","journal-title":"Cell Metabol."},{"key":"10.1016\/j.redox.2022.102582_bib46","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2022.01.004","article-title":"PUFA-induced metabolic enteritis as a fuel for crohn's disease","author":"Schw\u00e4rzler","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.redox.2022.102582_bib47","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1136\/gutjnl-2016-312431","article-title":"Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease","volume":"66","author":"Rotman","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.redox.2022.102582_bib48","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nature03434","article-title":"Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death","volume":"434","author":"Baines","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.redox.2022.102582_bib49","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1681\/ASN.2017020222","article-title":"FXR\/TGR5 dual agonist prevents progression of nephropathy in diabetes and obesity","volume":"29","author":"Wang","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.redox.2022.102582_bib50","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.2337\/db10-0019","article-title":"Diabetic nephropathy is accelerated by farnesoid X receptor deficiency and inhibited by farnesoid X receptor activation in a type 1 diabetes model","volume":"59","author":"Wang","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.redox.2022.102582_bib51","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nrgastro.2017.119","article-title":"Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis","volume":"15","author":"Jia","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.redox.2022.102582_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102452","article-title":"Chenodeoxycholic acid suppresses AML progression through promoting lipid peroxidation via ROS\/p38 MAPK\/DGAT1 pathway and inhibiting M2 macrophage polarization","volume":"56","author":"Liu","year":"2022","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2022.102582_bib53","article-title":"Substance P hinders bile acid-induced hepatocellular injury by modulating oxidative stress and inflammation","volume":"11","author":"Lee","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.redox.2022.102582_bib54","doi-asserted-by":"crossref","first-page":"15718","DOI":"10.1073\/pnas.0407076101","article-title":"The gut microbiota as an environmental factor that regulates fat storage","volume":"101","author":"B\u00e4ckhed","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.redox.2022.102582_bib55","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40168-019-0628-3","article-title":"Taxonomic profiling and populational patterns of bacterial bile salt hydrolase (BSH) genes based on worldwide human gut microbiome","volume":"7","author":"Song","year":"2019","journal-title":"Microbiome"},{"key":"10.1016\/j.redox.2022.102582_bib56","doi-asserted-by":"crossref","first-page":"6863","DOI":"10.1093\/nar\/gkab440","article-title":"HP1021 is a redox switch protein identified in Helicobacter pylori","volume":"49","author":"Szczepanowski","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.redox.2022.102582_bib57","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.3748\/wjg.v27.i25.3815","article-title":"Advances in paediatric nonalcoholic fatty liver disease: role of lipidomics","volume":"27","author":"Di Sessa","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.redox.2022.102582_bib58","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22083899","article-title":"Nonalcoholic fatty liver disease: focus on new biomarkers and lifestyle interventions","volume":"22","author":"Notarnicola","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.redox.2022.102582_bib59","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nrn3820","article-title":"Polyunsaturated fatty acids and their metabolites in brain function and disease","volume":"15","author":"Bazinet","year":"2014","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.redox.2022.102582_bib60","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","article-title":"Broadening horizons: the role of ferroptosis in cancer","volume":"18","author":"Chen","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.redox.2022.102582_bib61","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41467-019-14262-3","article-title":"TGF\u03b22-induced formation of lipid droplets supports acidosis-driven EMT and the metastatic spreading of cancer cells","volume":"11","author":"Corbet","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.redox.2022.102582_bib62","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nchembio.2238","article-title":"Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis","volume":"13","author":"Kagan","year":"2017","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.redox.2022.102582_bib63","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/hep.21763","article-title":"A lipidomic analysis of nonalcoholic fatty liver disease","volume":"46","author":"Puri","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.redox.2022.102582_bib64","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1002\/hep.23229","article-title":"The plasma lipidomic signature of nonalcoholic steatohepatitis","volume":"50","author":"Puri","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.redox.2022.102582_bib65","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.jhep.2020.03.046","article-title":"Targeted lipidomics reveals extensive changes in circulating lipid mediators in patients with acutely decompensated cirrhosis","volume":"73","author":"L\u00f3pez-Vicario","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.redox.2022.102582_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2020.109824","article-title":"Ferroptosis mediated by the interaction between Mfn2 and IRE\u03b1 promotes arsenic-induced nonalcoholic steatohepatitis","volume":"188","author":"Wei","year":"2020","journal-title":"Environ. Res."},{"key":"10.1016\/j.redox.2022.102582_bib67","doi-asserted-by":"crossref","first-page":"14376","DOI":"10.1073\/pnas.1921618117","article-title":"PEBP1 acts as a rheostat between prosurvival autophagy and ferroptotic death in asthmatic epithelial cells","volume":"117","author":"Zhao","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.redox.2022.102582_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113374","article-title":"An overview of ferroptosis in non-alcoholic fatty liver disease","volume":"153","author":"Wang","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.redox.2022.102582_bib69","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S2213-8587(14)70032-4","article-title":"Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome","volume":"2","author":"Yki-J\u00e4rvinen","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.redox.2022.102582_bib70","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1002\/hep.25778","article-title":"Pentoxifylline decreases oxidized lipid products in nonalcoholic steatohepatitis: new evidence on the potential therapeutic mechanism","volume":"56","author":"Zein","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.redox.2022.102582_bib71","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10166","article-title":"Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction","volume":"6","author":"Jiang","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.redox.2022.102582_bib72","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1210\/er.2007-0025","article-title":"Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism","volume":"29","author":"Holland","year":"2008","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.redox.2022.102582_bib73","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s12944-018-0855-9","article-title":"Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease","volume":"17","author":"Wasilewska","year":"2018","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.redox.2022.102582_bib74","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/j.apsb.2021.12.011","article-title":"Bile acid coordinates microbiota homeostasis and systemic immunometabolism in cardiometabolic diseases","volume":"12","author":"Guan","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.redox.2022.102582_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111087","article-title":"Cooperative action of gut-microbiota-accessible carbohydrates improves host metabolic function","volume":"40","author":"Tomioka","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.redox.2022.102582_bib76","doi-asserted-by":"crossref","DOI":"10.1038\/sj.embor.7400422","article-title":"Of mice and men. When it comes to studying ageing and the means to slow it down, mice are not just small humans","volume":"6","author":"Demetrius","year":"2005","journal-title":"EMBO Rep."},{"key":"10.1016\/j.redox.2022.102582_bib77","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1038\/s41591-018-0222-4","article-title":"Gut microbiota and intestinal FXR mediate the clinical benefits of metformin","volume":"24","author":"Sun","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.redox.2022.102582_bib78","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.redox.2022.102582_bib79","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1002\/hep.30975","article-title":"Probiotic lactobacillus rhamnosus GG prevents liver fibrosis through inhibiting hepatic bile acid synthesis and enhancing bile acid excretion in mice","volume":"71","author":"Liu","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.redox.2022.102582_bib80","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.3168\/jds.S0022-0302(99)75506-2","article-title":"Screening of lactic acid bacteria for bile salt hydrolase activity","volume":"82","author":"Tanaka","year":"1999","journal-title":"J. Dairy Sci."}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231722003548?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231722003548?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T06:28:56Z","timestamp":1761978536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213231722003548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":80,"alternative-id":["S2213231722003548"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2022.102582","relation":{},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microbiota-induced lipid peroxidation impairs obeticholic acid-mediated antifibrotic effect towards nonalcoholic steatohepatitis in mice","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2022.102582","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102582"}}